DE69522947T2 - Phenylxanthin-derivate - Google Patents
Phenylxanthin-derivateInfo
- Publication number
- DE69522947T2 DE69522947T2 DE69522947T DE69522947T DE69522947T2 DE 69522947 T2 DE69522947 T2 DE 69522947T2 DE 69522947 T DE69522947 T DE 69522947T DE 69522947 T DE69522947 T DE 69522947T DE 69522947 T2 DE69522947 T2 DE 69522947T2
- Authority
- DE
- Germany
- Prior art keywords
- pct
- sec
- date
- pub
- date jan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9415529A GB9415529D0 (en) | 1994-08-01 | 1994-08-01 | Phenyl xanthine derivatives |
PCT/GB1995/001808 WO1996004280A1 (en) | 1994-08-01 | 1995-07-31 | Phenyl xanthine derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69522947D1 DE69522947D1 (en) | 2001-10-31 |
DE69522947T2 true DE69522947T2 (de) | 2002-04-11 |
Family
ID=10759232
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69522947T Expired - Fee Related DE69522947T2 (de) | 1994-08-01 | 1995-07-31 | Phenylxanthin-derivate |
Country Status (9)
Country | Link |
---|---|
US (1) | US5776940A (de) |
EP (1) | EP0775141B1 (de) |
JP (1) | JPH10503767A (de) |
AT (1) | ATE206123T1 (de) |
AU (1) | AU3181395A (de) |
DE (1) | DE69522947T2 (de) |
ES (1) | ES2162934T3 (de) |
GB (1) | GB9415529D0 (de) |
WO (1) | WO1996004280A1 (de) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6514949B1 (en) | 1994-07-11 | 2003-02-04 | University Of Virginia Patent Foundation | Method compositions for treating the inflammatory response |
US6448235B1 (en) | 1994-07-11 | 2002-09-10 | University Of Virginia Patent Foundation | Method for treating restenosis with A2A adenosine receptor agonists |
GB9703044D0 (en) * | 1997-02-14 | 1997-04-02 | Glaxo Group Ltd | Phenyl xanthine esters and amides |
US6117878A (en) * | 1998-02-24 | 2000-09-12 | University Of Virginia | 8-phenyl- or 8-cycloalkyl xanthine antagonists of A2B human adenosine receptors |
EP0962491B1 (de) | 1998-06-02 | 2003-06-04 | Crompton Vinyl Additives GmbH | Cyanacetylharnstoffe zum Stabilisieren von halogenhaltigen Polymeren |
DK0967209T3 (da) | 1998-06-26 | 2003-03-24 | Crompton Vinyl Additives Gmbh | Hidtil ukendte NH2-modificerede 6-aminouraciler som stabilisatorer af halogenholdige polymerer |
EP0967245A1 (de) | 1998-06-26 | 1999-12-29 | Witco Vinyl Additives GmbH | 1,3-disubstituierte 6-Aminouracile zum Stabilisieren von halogenhaltigen Polymeren |
GB9817623D0 (en) * | 1998-08-13 | 1998-10-07 | Glaxo Group Ltd | Pharmaceutical compounds |
US7427606B2 (en) | 1999-02-01 | 2008-09-23 | University Of Virginia Patent Foundation | Method to reduce inflammatory response in transplanted tissue |
US6232297B1 (en) | 1999-02-01 | 2001-05-15 | University Of Virginia Patent Foundation | Methods and compositions for treating inflammatory response |
US7378400B2 (en) | 1999-02-01 | 2008-05-27 | University Of Virginia Patent Foundation | Method to reduce an inflammatory response from arthritis |
US6545002B1 (en) * | 1999-06-01 | 2003-04-08 | University Of Virginia Patent Foundation | Substituted 8-phenylxanthines useful as antagonists of A2B adenosine receptors |
US6322771B1 (en) | 1999-06-18 | 2001-11-27 | University Of Virginia Patent Foundation | Induction of pharmacological stress with adenosine receptor agonists |
HUP0302068A3 (en) * | 2000-07-20 | 2005-05-30 | Lauras As | Use of cox-2 inhibitors for treating or preventing immunodeficiency and pharmaceutical compositions containing them |
US6670334B2 (en) | 2001-01-05 | 2003-12-30 | University Of Virginia Patent Foundation | Method and compositions for treating the inflammatory response |
JP4514452B2 (ja) * | 2001-10-01 | 2010-07-28 | ユニバーシティ オブ バージニア パテント ファウンデーション | A2aアゴニスト活性を有する2−プロピルアデノシン・アナログおよびその組成物 |
US20080318983A1 (en) * | 2001-11-09 | 2008-12-25 | Rao Kalla | A2b adenosine receptor antagonists |
US7317017B2 (en) * | 2002-11-08 | 2008-01-08 | Cv Therapeutics, Inc. | A2B adenosine receptor antagonists |
US20080194593A1 (en) * | 2001-11-09 | 2008-08-14 | Rao Kalla | A2b adenosine receptor antagonists |
US6977300B2 (en) * | 2001-11-09 | 2005-12-20 | Cv Therapeutics, Inc. | A2B adenosine receptor antagonists |
US7304070B2 (en) * | 2001-11-09 | 2007-12-04 | Cv Therapeutics, Inc. | A2B adenosine receptor antagonists |
AU2002359365B2 (en) * | 2001-11-09 | 2008-07-10 | Gilead Sciences, Inc. | A2B adenosine receptor antagonists |
US20040072848A1 (en) * | 2002-02-26 | 2004-04-15 | Huber Brian E | Methods of treating irritable bowel syndrome and functional dyspepsia |
WO2003086408A1 (en) * | 2002-04-10 | 2003-10-23 | University Of Virginia Patent Foundation | Use of a2a adenosine receptor agonists for the treatment of inflammatory diseases |
US7576069B2 (en) * | 2004-08-02 | 2009-08-18 | University Of Virginia Patent Foundation | 2-polycyclic propynyl adenosine analogs having A2A agonist activity |
US7442687B2 (en) | 2004-08-02 | 2008-10-28 | The University Of Virginia Patent Foundation | 2-polycyclic propynyl adenosine analogs having A2A agonist activity |
CN101068825B (zh) | 2004-08-02 | 2013-05-08 | 弗吉尼亚大学专利基金会 | 具有a2a激动剂活性的具有修饰的5'-核糖基团的2-丙炔基腺苷类似物 |
RU2385322C2 (ru) * | 2004-09-01 | 2010-03-27 | Си Ви Терапьютикс, Инк. | Способ заживления ран с применением антагонистов аденозинового рецептора a2b |
US20070059740A1 (en) * | 2005-08-26 | 2007-03-15 | Linden Joel M | Method of targeting a2b adenosine receptor antagonist therapy |
US20080027022A1 (en) * | 2006-02-08 | 2008-01-31 | Linden Joel M | Method to treat gastric lesions |
WO2007120972A2 (en) | 2006-02-10 | 2007-10-25 | University Of Virginia Patent Foundation | Method to treat sickle cell disease |
US8297959B2 (en) * | 2006-05-03 | 2012-10-30 | Terapia Celular, Ln, Inc. | Systems for producing multilayered particles, fibers and sprays and methods for administering the same |
US8188063B2 (en) * | 2006-06-19 | 2012-05-29 | University Of Virginia Patent Foundation | Use of adenosine A2A modulators to treat spinal cord injury |
US8058259B2 (en) * | 2007-12-20 | 2011-11-15 | University Of Virginia Patent Foundation | Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists |
CN102260260B (zh) * | 2010-05-24 | 2014-08-06 | 中国科学院上海药物研究所 | 8-苯基黄嘌呤类化合物、其制备方法、包含该化合物的药物组合物及其用途 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4593095A (en) | 1983-02-18 | 1986-06-03 | The Johns Hopkins University | Xanthine derivatives |
GB8510758D0 (en) * | 1985-04-27 | 1985-06-05 | Wellcome Found | Compounds |
GB8610136D0 (en) * | 1986-04-25 | 1986-05-29 | Wellcome Found | Compounds |
US5015647A (en) * | 1987-04-24 | 1991-05-14 | Burroughs Wellcome Co. | Method for treating viral infections |
US4980379A (en) * | 1988-06-30 | 1990-12-25 | The University Of Virginia | Use of adenosine antagonists in the treatment of bradyarrhythmias and hemodynamic depression associated with cardiopulmonary resucitation and/or cardiovascular collapse |
US5300298A (en) * | 1992-05-06 | 1994-04-05 | The Pennsylvania Research Corporation | Methods of treating obesity with purine related compounds |
TW252044B (de) | 1992-08-10 | 1995-07-21 | Boehringer Ingelheim Kg | |
JP2613355B2 (ja) * | 1992-09-28 | 1997-05-28 | 協和醗酵工業株式会社 | パーキンソン氏病治療剤 |
-
1994
- 1994-08-01 GB GB9415529A patent/GB9415529D0/en active Pending
-
1995
- 1995-07-31 ES ES95927805T patent/ES2162934T3/es not_active Expired - Lifetime
- 1995-07-31 WO PCT/GB1995/001808 patent/WO1996004280A1/en active IP Right Grant
- 1995-07-31 EP EP95927805A patent/EP0775141B1/de not_active Expired - Lifetime
- 1995-07-31 JP JP8506312A patent/JPH10503767A/ja not_active Ceased
- 1995-07-31 US US08/776,454 patent/US5776940A/en not_active Expired - Fee Related
- 1995-07-31 AT AT95927805T patent/ATE206123T1/de not_active IP Right Cessation
- 1995-07-31 AU AU31813/95A patent/AU3181395A/en not_active Abandoned
- 1995-07-31 DE DE69522947T patent/DE69522947T2/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0775141B1 (de) | 2001-09-26 |
DE69522947D1 (en) | 2001-10-31 |
AU3181395A (en) | 1996-03-04 |
GB9415529D0 (en) | 1994-09-21 |
JPH10503767A (ja) | 1998-04-07 |
ES2162934T3 (es) | 2002-01-16 |
EP0775141A1 (de) | 1997-05-28 |
US5776940A (en) | 1998-07-07 |
ATE206123T1 (de) | 2001-10-15 |
WO1996004280A1 (en) | 1996-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69522947T2 (de) | Phenylxanthin-derivate | |
MX9203053A (es) | Derivados de aza nor bornano. | |
DE59409312D1 (de) | Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten | |
BR9509708B1 (pt) | compostos e composições endoparasiticidas. | |
FI932229A (fi) | Azabicykliska bryggderivat | |
ES2144151T3 (es) | Benzotiazepinas hipolipidemicas. | |
ES2092113T3 (es) | Derivados fluoroalcoxibencilamino de heterociclos que contienen nitrogeno. | |
NO963439L (no) | Sammensetninger inneholdende mikronisert vebivolol | |
DE69516503T2 (de) | Piperidinderivate mit paf antagonistischer wirkung | |
FI945975A (fi) | Haarautuneella aminoryhmällä substituoituja tiatsoleja, menetelmiä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia | |
ES2135769T3 (es) | Derivados de isotiourea como inhibidores de no-sintasa. | |
DE69413831T2 (de) | Phenoxyphenylcyclopentenyl-hydroxyharnstoffe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |